Welcome to a new episode of "WisBusiness: The Show," a twice-a-month Web show covering state business news and issues. This episode of “WisBusiness.com: The...
MADISON, Wis., Aug. 1, 2017 /PRNewswire/ -- Moxe announced today the release of Convergence – a solution redefining the exchange of clinical information by integrating health...
As a post-doctoral researcher at the University of Wisconsin-Madison, Bob Lindner used to develop artificial intelligence to better understand the stars, programming ways...
Invenra, a Madison startup involved in the race to find drugs that will beat cancer, says it is teaming with Merck, one of...
Exact Sciences Corp. gave a rosy report Tuesday on its finances for the second quarter of 2017, and said a major study on its...
A skin tissue product to treat serious burns — developed and manufactured in Madison — will get special attention from the FDA. StrataGraft is...
Kiio, a Madison-based tech company with a health engagement platform, is partnering with the Department of Defense to test and develop a new...
Today Kiio Inc. announced the enrollment of the first human subjects in the company’s $1.3 million multi-year, multi-institutional Department of Defense project to develop and...
MADISON, Wis. - Amyotrophic lateral sclerosis, ALS, is a devastating disease with no known cure or effective treatments. A research project at UW-Madison...
The Wisconsin Economic Development Corporation has certified Varigen Biosciences as a Qualified New Business Venture (QNBV), the organization announced recently. According to a release, QNBV allows investors...